Xeriant Swings to $1.93M Net Profit in H1 FY2026 Despite Q2 Loss

Xeriant Inc. posted net income of $1.93 million for the six months ending December 31, 2025, reversing a $789,491 loss in the prior-year period. The company reported a loss of $297,593 in the December quarter, narrowing from a $417,269 loss a year earlier. Read more earnings reports.

Operating expenses for the six-month period fell 23% to $535,137 from $694,378 in the same stretch of fiscal 2025. The December quarter alone saw operating expenses drop 31% to $231,062 from $335,583.

Interest expense for the half-year period declined to $80,605 from $112,996, while the company recorded a tax expense of $108,657 compared to zero in the prior-year period. The December quarter included a tax benefit of $15,928.

Cash and restricted cash stood at $76,533 as of December 31, 2025, down 70% from $254,195 a year earlier. The company burned $383,317 in cash from operations during the six-month period, an improvement from the $750,922 outflow in the prior year.

Xeriant raised $415,000 from financing activities during the half, up from $352,000 in the year-ago period. Total assets grew to $103,440 from $68,219 at the end of June 2025.

Total liabilities declined to $5.74 million from $8.77 million six months earlier. The company reported a stockholders' deficit of $2.76 million as of December 31, 2025, narrowing from a deficit of $5.82 million at the end of June.

Common shares outstanding increased to 862.76 million from 695.75 million during the six-month period. Research and development expenses rose to $70,269 for the half from $26,576 in the prior year.